Work Area: Trade secrets

Latest content

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Rise of AI continues to re-write life sciences IP strategies in 2022

A spate of pharma-high tech innovation partnerships have dominated opening days of the year

11 January 2022

AbbVie heads to the ITC in dramatic final battle over Humira biosimilars

Chicago-based company seeking to exclude Alvotech’s adalimumab product from the US market for alleged trade secret misappropriation

10 January 2022

The biggest biopharma patent stories of the year

From President Biden’s backing for a covid IP waiver through a new linkage system in China to big changes in Brazil, it was an action-packed 2021 for the life sciences industries

21 December 2021

The biggest Asia-Pacific IP stories of 2021

Beyond China, there was a lot going on in a market that is home to some of the world’s most important patent-producing businesses

21 December 2021

The 2021 trends that shaped the IP market in five major industries

In-house experts highlight the year’s most important patent developments in auto, life sciences, software, semiconductors and telecoms

20 December 2021

Apple joins Uniloc in opposing court-mandated release of details of the NPE's patent licensing deals

If the CAFC upholds a lower court’s refusal to redact licensees’ identities and information on how much they paid, it could prejudice the interests of both sides in future negotiations, dealmakers say

13 December 2021

Germany’s new government is the last hope for covid IP waiver advocates

A post-Merkel change of approach by the country’s recently agreed traffic light coalition government could change the momentum of TRIPS suspension talks – but don’t bet on it

07 December 2021

Vidal looks all set to lead the USPTO after confident Senate hearing

In a strong display, the Biden administration's choice to lead the agency addressed Section 101 reform and Fintiv discretionary denials, but may have left a hostage to fortune on SEP/FRAND

02 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Unlock unlimited access to all IAM content